Skip to main content
TipRanks
Go Ultimate75% OFF

Microbix Biosystms (MBX) Stock Statistics & Valuation Metrics

39 Followers

Total Valuation

Microbix Biosystms has a market cap or net worth of CAD 40.41M. The enterprise value is CAD 40.83M.

Market Cap
CAD 40.41M
Enterprise Value
CAD 40.83M

Share Statistics

Microbix Biosystms has 136,968,660 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
136,968,660
Owned by Insiders
4.12%
Owned by Institutions
―

Financial Efficiency

Microbix Biosystms’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -4.41%.

Return on Equity (ROE)
-0.08
Return on Assets (ROA)
-0.06
Return on Invested Capital (ROIC)
-4.41%
Return on Capital Employed (ROCE)
-0.05
Revenue Per Employee
185.85K
Profits Per Employee
-22.46K
Employee Count
100
Asset Turnover
0.50
Inventory Turnover
0.95

Valuation Ratios

The current PE Ratio of Microbix Biosystms is -7.79. Microbix Biosystms’s PEG ratio is 0.06.

PE Ratio
-7.79
PS Ratio
2.45
PB Ratio
1.52
Price to FCF
-9.69
Price to Operating Cash Flow
-11.23
PEG Ratio
0.06

Income Statement

In the last 12 months, Microbix Biosystms had revenue of 18.59M and earned -2.25M in profits. Earnings per share was -0.02.

Revenue
18.59M
Gross Profit
9.85M
Operating Income
-1.58M
Pretax Income
-2.30M
Net Income
-2.25M
EBITDA
428.23K
Earnings Per Share (EPS)
-0.02

Cash Flow

In the last 12 months, operating cash flow was -3.29M and capital expenditures -595,167, giving a free cash flow of -3.89M billion.

Operating Cash Flow
-3.29M
Free Cash Flow
-3.89M
Free Cash Flow per Share
-0.03

Dividends & Yields

Microbix Biosystms pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-10.32%
Earnings Yield
-13.21%

Stock Price Statistics

Beta
0.06
52-Week Price Change
17.02%
50-Day Moving Average
0.30
200-Day Moving Average
0.28
Relative Strength Index (RSI)
43.20
Average Volume (3m)
27.94K

Important Dates

Microbix Biosystms upcoming earnings date is Dec 17, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 13, 2026
Next Earnings Date
Dec 17, 2026
Ex-Dividend Date
―

Financial Position

Microbix Biosystms as a current ratio of 8.48, with Debt / Equity ratio of 24.36%

Current Ratio
8.48
Quick Ratio
5.17
Debt to Market Cap
0.14
Net Debt to EBITDA
-12.48
Interest Coverage Ratio
-1.66

Taxes

In the past 12 months, Microbix Biosystms has paid -55.73K in taxes.

Income Tax
-55.73K
Effective Tax Rate
0.02

Enterprise Valuation

Microbix Biosystms EV to EBITDA ratio is -16.18, with an EV/FCF ratio of -9.57.

EV to Sales
2.42
EV to EBITDA
-16.18
EV to Free Cash Flow
-9.57
EV to Operating Cash Flow
-11.30

Balance Sheet

Microbix Biosystms has CAD 7.16M in cash and marketable securities with CAD 6.72M in debt, giving a net cash position of CAD 440.07K billion.

Cash & Marketable Securities
CAD 7.16M
Total Debt
CAD 6.72M
Net Cash
CAD 440.07K
Net Cash Per Share
CAD 0.00
Tangible Book Value Per Share
CAD 0.16

Margins

Gross margin is 45.90%, with operating margin of -27.69%, and net profit margin of -31.72%.

Gross Margin
45.90%
Operating Margin
-27.69%
Pretax Margin
-32.08%
Net Profit Margin
-31.72%
EBITDA Margin
-14.94%
EBIT Margin
-27.03%

Analyst Forecast

The average price target for Microbix Biosystms is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-27.13%
EPS Growth Forecast
-1752.63%

Scores

Smart Score
―
AI Score
54